Metformin can cause lactic acidosis, but it’s exceptionally rare. The condition, known as metformin-associated lactic acidosis (MALA), occurs in roughly 3 to 10 cases per 100,000 patient-years based on a meta-analysis of 65 studies. For the vast majority of people taking metformin with healthy kidneys, the risk is negligible. Problems arise almost exclusively when something else goes wrong first, like kidney failure, severe dehydration, or a serious infection that prevents the body from clearing the drug normally.
Why Metformin Raises Lactate Levels
To understand the connection, it helps to know what metformin does at a cellular level. One of metformin’s main jobs is lowering blood sugar by blocking the liver from making new glucose, a process called gluconeogenesis. It does this partly by inhibiting an enzyme involved in shuttling energy between different compartments of liver cells. When this enzyme is blocked, the chemical balance inside liver cells shifts in a way that prevents lactate from being converted into pyruvate, its usual next step in metabolism.
The result is a roughly 3-fold increase in the ratio of lactate to pyruvate in the liver. Under normal circumstances, your kidneys and liver clear this extra lactate without trouble, and blood lactate stays within a safe range. But when the body’s ability to process or excrete lactate is overwhelmed, it accumulates in the blood faster than it can be cleared. That’s when lactic acidosis develops.
Who Is Actually at Risk
MALA almost never strikes out of the blue. It develops when one or more additional problems pile on top of metformin use. The most important risk factor is kidney impairment, because the kidneys are responsible for eliminating metformin from the body. When they slow down, metformin builds up to dangerous concentrations. A large U.S. cohort study of roughly one million people with diabetes found that metformin was associated with acidosis only when kidney filtration rate (eGFR) dropped below 30 mL/min/1.73 m².
Other conditions that raise the risk include:
- Severe dehydration: Vomiting, diarrhea, or poor fluid intake can cause acute kidney failure. In clinical case series, dehydration from gastrointestinal illness was one of the most common triggers.
- Sepsis or serious infection: Infections like pneumonia reduce blood flow to tissues, which impairs lactate clearance and can precipitate MALA.
- Liver disease: Since the liver is a major site for lactate metabolism, significant liver impairment removes a key safety buffer.
- Heart failure: Reduced cardiac output means less blood flow to the kidneys, liver, and other tissues, slowing both metformin clearance and lactate processing.
- Heavy alcohol use: Alcohol independently shifts the body’s chemistry in a direction that favors lactate accumulation.
In practice, most cases involve a combination of these factors rather than a single trigger.
Kidney Thresholds for Safe Use
Current guidelines use eGFR, a measure of how well your kidneys filter blood, to determine whether metformin is safe. Metformin is considered safe at full doses when eGFR is 45 or above. Between 30 and 44, the dose should be limited to no more than 1,000 mg daily. Below 30, metformin is contraindicated entirely.
These thresholds are the reason your doctor checks kidney function before prescribing metformin and periodically after you start it. If you develop an illness that could affect your kidneys, like a severe stomach bug with days of vomiting, that’s a situation where temporary metformin accumulation becomes a real concern.
Symptoms to Watch For
One of the challenges with MALA is that early symptoms overlap with common metformin side effects. Initial complaints typically include nausea, vomiting, abdominal pain, and diarrhea. These are the same gastrointestinal symptoms many people experience when starting metformin, which makes it easy to dismiss them.
As acidosis worsens, symptoms shift toward shortness of breath, rapid breathing, dizziness, lightheadedness, and deep fatigue. The rapid breathing happens because the body is trying to blow off carbon dioxide to compensate for the acid building up in the blood. In severe cases, confusion, altered mental status, or even coma can develop. A racing heart rate is also common.
The key distinction is context. Nausea on its own after taking metformin with food is unremarkable. Nausea combined with days of diarrhea, poor fluid intake, and increasing fatigue or shortness of breath is a different situation entirely.
How Serious Is MALA When It Happens
Though rare, MALA is dangerous when it does occur. Mortality rates have improved significantly over the decades, falling from around 50% in the period between 1960 and 2000 to roughly 25% in more recent data. The improvement likely reflects better recognition, faster treatment, and more accessible dialysis.
Clinically, MALA is defined by a blood lactate level above 5 mmol/L and a blood pH below 7.35 (normal blood pH is tightly regulated around 7.4). Some patients present with extreme values. The severity depends on how high metformin levels have climbed, how much lactate has accumulated, and whether the underlying trigger, like infection or kidney failure, can be reversed quickly.
How MALA Is Treated
The primary treatment for severe MALA is dialysis, which physically removes metformin from the blood and helps correct the acid-base imbalance. Intermittent hemodialysis is generally preferred over continuous methods because it clears metformin much faster. However, because metformin distributes widely throughout body tissues, dialysis alone sometimes isn’t enough. Metformin can leach back into the blood from tissues after a dialysis session ends, which is why extended or repeated treatments are sometimes necessary.
Interestingly, giving sodium bicarbonate to neutralize the acid, which might seem like an obvious fix, can actually make things worse by paradoxically worsening acidosis and weakening heart function. Treatment focuses on supporting the body while removing the drug and addressing whatever triggered the crisis in the first place, whether that’s treating an infection, restoring hydration, or stabilizing kidney function.
Metformin and Contrast Dye Procedures
If you take metformin and need a CT scan or other imaging that uses iodinated contrast dye, your medical team may ask you to pause metformin temporarily. The concern isn’t the contrast itself interacting with metformin. It’s that contrast dye can temporarily stress the kidneys, and if kidney function dips, metformin could accumulate.
For people with an eGFR above 60 who receive a large volume of contrast (more than 100 mL, typical for abdominal or vascular imaging), guidelines recommend stopping metformin at the time of the procedure and restarting no earlier than 48 hours later. For smaller contrast volumes in people with normal kidney function, pausing may not be necessary at all. If your eGFR is below 60, the precautions are stricter: metformin is stopped at the time of contrast administration and restarted only after kidney function is confirmed stable, typically 48 hours later.
Recent guideline updates from the American College of Radiology in 2023 have actually relaxed some of these rules compared to earlier versions, reflecting growing evidence that contrast-related kidney injury is less common than previously thought in patients with moderate kidney function.